Drug Topics November/December 2025

Delgocitinib is a topical treatment for chronic hand eczema, enhancing options for patients with severe symptoms.

Oral semaglutide (Rybelsus) reduces the risk of major adverse cardiovascular events in adults with high-risk type 2 diabetes, based on data from the SOUL trial.

The role of community pharmacists is expanding to combat antibiotic resistance and enhance antimicrobial stewardship.

Daniel Cate, PharmD, and his wife, Callie, own a pharmacy in Little Rock, Arkansas, that serves up donuts and prescriptions.

Pharmacists enhance asthma care by bridging knowledge gaps, improving medication adherence, and providing cost-effective treatment options for patients.

Pharmacists play a crucial role in preventing cardiometabolic conditions through screenings, risk assessments, and lifestyle interventions, enhancing public health.

Vaccine hesitancy rises as new recommendations emerge, highlighting pharmacists’ crucial role in addressing misinformation and improving immunization rates.

Pharmacists play a crucial role in winter health, offering vaccinations, managing chronic conditions, and combating misinformation to keep communities healthy.

Key sessions from the National Community Pharmacists Association 2025 Annual Convention & Expo highlight pharmacy benefit manager reform, pneumococcal vaccines, and billable services.

Tardive dyskinesia presents significant challenges for patients, but new FDA-approved treatments offer hope for improved management and quality of life.